Identification of pharmacological chaperones for misfolded proteins
Identification of pharmacological chaperones for misfolded proteins
批准号:
7340675
负责人:
Chandra L Tucker
金额:
$14.04万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-03-01 至 2010-02-28
关键词:
AffectAlanine-glyoxylate aminotransferaseAmyloidAmyloidosisBindingBiochemicalBiologicalBiological AssayCellsChemicalsClassComplementCoupledCystic FibrosisDataDeuteriumDevelopmentDiabetes MellitusDihydrofolate ReductaseDiseaseDisease modelDrug Delivery SystemsEnzymesEvaluationFoundationsGalactosidaseGeneric DrugsGenomicsGoalsGrowthHomologous GeneHumanHydrogenInterventionKnowledgeLigand BindingLigandsMalignant NeoplasmsMass Spectrum AnalysisMeasurementMetabolicMethodologyModelingMolecular ChaperonesMutationObesityPathway interactionsPerformancePhenotypePrimary HyperoxaluriaPrion DiseasesProtein ConformationProteinsQuality ControlRangeRateReporterReportingRoleScreening procedureSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationStudy modelsTemperatureTestingTherapeuticVariantWorkYeastsalanine-glyoxylate transaminase 1basebiological adaptation to stressconceptdesignenhancing factorglucosidasehigh throughput screeninghuman diseaseinterestnumb proteinpolyglutamineprotein foldingprotein functionprotein misfoldingsensorsmall moleculeyeast genetics
中文摘要
描述(由申请人提供):稳定蛋白质天然折叠的化合物,称为药理学伴侣,作为治疗淀粉样蛋白疾病、囊性纤维化和癌症等疾病的治疗药物,具有很大的前景,这些疾病的病因是蛋白质错误折叠。寻找此类化合物的一个主要障碍是缺乏通用的高通量测定方法来鉴定稳定分子。缺乏适当的分析通常是一个不可逾越的障碍,蛋白质不具有容易测定的表型。这里描述的是三个独立的分析,可用于高通量筛选,以确定潜在的药理学伴侣的发展。其中两种检测方法是通用的:也就是说,它们被设计用于任何蛋白质,不需要了解蛋白质的功能。这些分析构成了一个独特的平台,不仅可以识别候选伴侣,还可以分析它们的作用模式。本文描述了测试每种检测方法能力的工作,首先检查各种蛋白质的功能潜力,其次对模型错误折叠、疾病蛋白质变异进行化学筛选,最后检查这些模型研究中获得的命中点的生物学作用。重要的是,这些检测预计将是快速、直接和可转移的,并将为识别与多种蛋白质靶点相互作用的药理学伴侣提供基本方法。具体目标是:目标1。以酵母为基础的错误折叠蛋白拯救检测方法的建立。(a)互补试验。在这项试验中,人类疾病蛋白与酵母菌株互补,如果该蛋白是功能性的,则该菌株生长健壮,但显示出温度敏感的生长与错误折叠的变体。该方法将在11,000种化合物的高通量筛选中与人类AGT一起开发和测试。(b)基于dhfr的蛋白质错误折叠传感器。在这个实验中,一种不稳定的蛋白质与必需酶二氢叶酸还原酶(DHFR)偶联,DHFR作为报告基因。这种方法的通用性将在高通量筛选中用几种人类蛋白质进行测试,包括AGT和1-半乳糖苷酶A,如(A)所示。目标2。基于质谱法的配体诱导蛋白质稳定的SUPREX测定方法的评价。该方法使用氢-氘交换和MALDI质谱法来报告配体诱导的稳定性变化。我们将评估该检测方法的有效性和通用性,以识别包括AGT、1-半乳糖苷酶A和2-葡萄糖苷酶在内的疾病蛋白的药理学伴侣。疾病变异将通过高通量化学筛选来稳定配体。目标3。评估命中与蛋白质错误折叠的相关性。将比较基于细胞和基于质谱的筛选的数据。基于细胞和质谱的筛查中常见的命中值将受到Kd值测量的影响;将研究基于细胞的分析所独有的命中对细胞内一般折叠和/或质量控制途径的潜在影响。错误折叠的蛋白质是导致许多人类疾病的原因,但很少有通用的测定方法可以有效地识别可能纠正缺陷蛋白质折叠的化合物或分子。在本提案中,我们描述了三种独立分析的发展,可用于高通量筛选增强蛋白质折叠的因素。由于这些检测是稳健的、可推广的,并且可以扩展到任何感兴趣的错误折叠蛋白质,它们有望大大加快识别错误折叠疾病的治疗性化合物。
英文摘要
DESCRIPTION (provided by applicant): Compounds that stabilize a protein's native fold, termed pharmacological chaperones, hold great promise as therapeutics for treating diseases such as amyloid diseases, cystic fibrosis, and forms of cancer, that have etiological origins in protein misfolding. A major obstacle in the search for such compounds is the lack of generic high-throughput assays to identify stabilizing molecules. The lack of an appropriate assay is often an insurmountable obstacle for proteins that do not have easily assayable phenotypes. Described here is the development of three independent assays that can be used in high-throughput screens to identify potential pharmacological chaperones. Two of these assays are generic: that is, they are designed to be used with any protein and do not require knowledge of the protein's function. Together the assays constitute a unique platform not only for the identification of candidate chaperones, but also for dissecting their mode of action. Work is described to test the capabilities of each assay, first examining potential for functioning with a wide range of proteins, second carrying out chemical screens with model misfolded, disease protein variants, and finally examining the biological roles of hits obtained in these model studies. Importantly, the assays are expected to be rapid, straightforward, and transferable, and will provide basic methodologies for identifying pharmacological chaperones that interact with a wide variety of protein targets. The specific aims are: Aim 1. Establishment of yeast-based assays for rescue of misfolded proteins. (a) Complementation assay. In this assay, human disease protein complements a yeast strain such that the strain grows robustly if the protein is functional, but shows temperature-sensitive growth with a misfolded variant. The assay will be developed and tested with human AGT in high-throughput screens of 11,000 compounds. (b) DHFR-based protein misfolding sensor. In this assay, an unstable protein is coupled to the essential enzyme dihydrofolate reductase (DHFR), which acts as a reporter. The generality of this approach will be tested with several human proteins, including AGT and 1-galactosidase A, in high-throughout screening as in (a). Aim 2. Evaluation of a mass-spectrometry-based SUPREX assay for ligand-induced protein stabilization. This approach uses hydrogen-deuterium exchange and MALDI mass-spectrometry to report ligand-induced stability changes. We will assess the efficacy and generality of this assay for identification of pharmacological chaperones using disease proteins including AGT, 1-galactosidase A, and 2-glucosidase. Disease variants will be screened in high-throughput chemical screens for stabilizing ligands. Aim 3. Evaluation of relevance of hits to protein misfolding. Data from the cell-based and mass- spectrometry based screens will be compared. Hits that are common to the cell- and mass-spectrometry based screens will be subject to Kd value measurements; hits that are exclusive to the cell-based assays will be investigated for potential effects on general folding and/or quality control pathways within the cell. Misfolded proteins are responsible for many human diseases, yet few generic assays exist for efficiently identifying compounds or molecules that may correct defective protein folding. In this proposal, we describe the development of three independent assays that can be used in high-throughput screens for factors that enhance protein folding. As these assays are robust, generalizable, and can be extended to any misfolded protein of interest, they are expected to greatly accelerate identification of therapeutic compounds for misfolding disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Uncovering new approaches to manipulate and probe biochemical processes with spatial and temporal precision.
-
批准号:10425239
-
项目类别:
-
资助金额:$43.04万
-
财政年份:2020
-
负责人:Chandra L Tucker
-
依托单位:
Uncovering new approaches to manipulate and probe biochemical processes with spatial and temporal precision.
-
批准号:10581649
-
项目类别:
-
资助金额:$43.04万
-
财政年份:2020
-
负责人:Chandra L Tucker
-
依托单位:
Uncovering new approaches to manipulate and probe biochemical processes with spatial and temporal precision.
-
批准号:10132357
-
项目类别:
-
资助金额:$43.04万
-
财政年份:2020
-
负责人:Chandra L Tucker
-
依托单位:
Optogenetic control of protein assembly
-
批准号:9434099
-
项目类别:
-
资助金额:$19.44万
-
财政年份:2017
-
负责人:Chandra L Tucker
-
依托单位:
Control of Protein Activity Via Light Stimulated Dimerizers
-
批准号:9324407
-
项目类别:
-
资助金额:$23.84万
-
财政年份:2016
-
负责人:Chandra L Tucker
-
依托单位:
Control of Protein Activity Via Light Stimulated Dimerizers
-
批准号:8441485
-
项目类别:
-
资助金额:$32.03万
-
财政年份:2012
-
负责人:Chandra L Tucker
-
依托单位:
Control of Protein Activity Via Light Stimulated Dimerizers
-
批准号:8827806
-
项目类别:
-
资助金额:$41.01万
-
财政年份:2012
-
负责人:Chandra L Tucker
-
依托单位:
Control of Protein Activity Via Light Stimulated Dimerizers
-
批准号:9175615
-
项目类别:
-
资助金额:$39.41万
-
财政年份:2012
-
负责人:Chandra L Tucker
-
依托单位:
Control of Protein Activity Via Light Stimulated Dimerizers
-
批准号:8641400
-
项目类别:
-
资助金额:$33.3万
-
财政年份:2012
-
负责人:Chandra L Tucker
-
依托单位:
Control of Protein Activity Via Light Stimulated Dimerizers
-
批准号:9321377
-
项目类别:
-
资助金额:$39.11万
-
财政年份:2012
-
负责人:Chandra L Tucker
-
依托单位:
Control of Protein Activity Via Light Stimulated Dimerizers
-
批准号:8221121
-
项目类别:
-
资助金额:$33.06万
-
财政年份:2012
-
负责人:Chandra L Tucker
-
依托单位:
Control of Protein Activity Via Light Stimulated Dimerizers
-
批准号:8841854
-
项目类别:
-
资助金额:$8.06万
-
财政年份:2012
-
负责人:Chandra L Tucker
-
依托单位:
Control of Protein Activity Via Light Stimulated Dimerizers
-
批准号:9752564
-
项目类别:
-
资助金额:$38.57万
-
财政年份:2012
-
负责人:Chandra L Tucker
-
依托单位:
Analysis of PH1-associated alanine:glyoxylate aminotranferase (AGT) using yeast
-
批准号:7903776
-
项目类别:
-
资助金额:$14.58万
-
财政年份:2009
-
负责人:Chandra L Tucker
-
依托单位:
Analysis of PH1-associated alanine:glyoxylate aminotranferase (AGT) using yeast
-
批准号:7854576
-
项目类别:
-
资助金额:$1.18万
-
财政年份:2009
-
负责人:Chandra L Tucker
-
依托单位:
Analysis of PH1-associated alanine:glyoxylate aminotranferase (AGT) using yeast
-
批准号:7923388
-
项目类别:
-
资助金额:$33.05万
-
财政年份:2008
-
负责人:Chandra L Tucker
-
依托单位:
Analysis of PH1-associated alanine:glyoxylate aminotranferase (AGT) using yeast
-
批准号:7668385
-
项目类别:
-
资助金额:$33.15万
-
财政年份:2008
-
负责人:Chandra L Tucker
-
依托单位:
Analysis of PH1-associated alanine:glyoxylate aminotranferase (AGT) using yeast
-
批准号:8133318
-
项目类别:
-
资助金额:$31.87万
-
财政年份:2008
-
负责人:Chandra L Tucker
-
依托单位:
Identification of pharmacological chaperones for misfolded proteins
-
批准号:7569438
-
项目类别:
-
资助金额:$14.04万
-
财政年份:2008
-
负责人:Chandra L Tucker
-
依托单位:
ENGINEERING A YEAST SENSOR OF LIGAND-BINDING
-
批准号:6525700
-
项目类别:
-
资助金额:$4.62万
-
财政年份:2000
-
负责人:Chandra L Tucker
-
依托单位:
海外基金